JPS58148963A - Reagent for measuring bound material of alpha-1- antitrypsin-trypsin in human body fluid by sandwich method - Google Patents

Reagent for measuring bound material of alpha-1- antitrypsin-trypsin in human body fluid by sandwich method

Info

Publication number
JPS58148963A
JPS58148963A JP3171382A JP3171382A JPS58148963A JP S58148963 A JPS58148963 A JP S58148963A JP 3171382 A JP3171382 A JP 3171382A JP 3171382 A JP3171382 A JP 3171382A JP S58148963 A JPS58148963 A JP S58148963A
Authority
JP
Japan
Prior art keywords
antibody
alpha1
trypsin
enzyme
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3171382A
Other languages
Japanese (ja)
Inventor
Mamoru Sugiura
衛 杉浦
Kazuyuki Hirano
和行 平野
Shinobu Hayakawa
忍 早川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruko Pharmaceutical Co Ltd
Original Assignee
Maruko Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruko Pharmaceutical Co Ltd filed Critical Maruko Pharmaceutical Co Ltd
Priority to JP3171382A priority Critical patent/JPS58148963A/en
Publication of JPS58148963A publication Critical patent/JPS58148963A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To enable the measurement of the alpha1-antitrypsin (AT).trypsin (T) in human bodily fluid with good accuracy by using the enzyme-signaled antibody of the anti-alpha1- AT antibody and insolubilized anti-T antibody obtained respectively by sensitizing the human alpha1-AT and T in domestic rabbits. CONSTITUTION:The enzyme-signaled anti-alpha1-AT antibody wherein the anti-alpha1-AT antibody obtained by sensitizing the alpha1-AT in refined human sera in domestic rabbit is bound with peroxidase or beta-galactosidase or the like and the insolubilized anti-T antibody wherein the anti-T antibody obtained by sensitizing the trypsine of the human pancreas in domestic rabit is bound with glass beads, polystyrene, etc. are prepd. The insolubilized anti-T antibody is added to human bodily fluid (serum) and after the reaction, the enzyme-signaled anti-alpha1-AT antibody is added thereto. After the reaction, the enzyme activity of the insolubilized anti-T antibody-alpha1-AT T-enzyme-signaled anti-alpha1- AT antibody is measured by measuring the intensity of the color or fluoresence developed by addition of a suitable reagent. The measured activity is contrasted with a standard curve obtained beforehand, whereby the alpha1-AT.T in the serum are measured with good accuracy.

Description

【発明の詳細な説明】 本btaはヒト体液中アルファーー1−アンナトリプシ
ン・トリプシン結合物(以下α1−ムチ−丁と称す)を
サンドウィッチ法による酵素免疫学的方法により測定す
る試11KMするO血清中トリプシン量は、従来、放射
性免!III定法により測定され膵疾患との関連が論じ
られて自走が[f:1ias、 E、* M、 R@d
sbav、 am−丁。
DETAILED DESCRIPTION OF THE INVENTION The present BTA is a 11KM test in which the alpha-1-annatrypsin trypsin conjugate (hereinafter referred to as α1-much-trypsin) in human body fluids is measured by an enzyme immunological method using the sandwich method. Conventionally, the amount of trypsin is determined by radioactive immunity! III standard method, and its relationship with pancreatic disease was discussed.
sbav, am-ding.

W@od、 Lamest 鳳: 66−68e (1
977) )、七の自清中存在様式tie雑であり、ト
リプシノーゲン及びアルファー−1−アンチトリプシン
(ヘームi)。
W@od, Lamest Otori: 66-68e (1
977)), which is present in the autolyte of seven different tie types, including trypsinogen and alpha-1-antitrypsin (Heme I).

アルファー−2−マクログロブリン等の阻害物質との結
合物などが知られて−る( By・−rl@k。
Binding substances with inhibitory substances such as alpha-2-macroglobulin are known (By・-rl@k).

J、 W、、  M、 C,G*ekas、 C,La
rgmam、 M、Fasutt。
J, W,, M, C, G*ekas, C, La
rgmam, M. Fasutt.

and  J、 H,J@hns*n s ム閣、 J
、 Pkyslsl、 237eE 474−1i: 
480 (1979)及びB@rgstrWm、ム、 
amdK、   0hlsion  s  Hopp*
−8*yl @r’s  Z、  Physiel。
and J, H, J@hns*n smukaku, J
, Pkyslsl, 237eE 474-1i:
480 (1979) and B@rgstrWm, Mu.
amdK, 0hlsion's Hopp*
-8*yl @r's Z, Physiel.

Ch@w、 遍1677−681 (197g) )。Ch@w, 1677-681 (197g)).

しかしながら、現在測定されるイムノリアクティブトリ
プシン量はこれらの愉雑な存在様式を示すトリプシンを
全体として示すものであり、必ずしも正−な細定法とは
考えられない。tえ、イムノリアクティブトリックンが
正常人にてもその存在か尭られるのに対し、α、 −A
TLIT td膵疾患勢では紹められるが、正常人にお
いては、はとんど漏示不可能な量が存在するのみである
との報告がなされており[Borgstr6m l A
、 and  K、0hlssonxScand、 J
、 Cl1n、 Lab、 Invest、 36 8
09−814(19〕6)〕、〕α、−AT−T O漏
定法の開発はl!疾患診断に有用な手段を与えることに
なると考えられる。
However, the currently measured amount of immunoreactive trypsin indicates trypsin that exhibits these complicated forms of existence as a whole, and is not necessarily considered to be a correct determination method. te, whereas the existence of immunoreactive trichons can be deduced even in normal people, α, −A
TLIT tdAlthough it is introduced in patients with pancreatic disease, it has been reported that in normal people, it exists only in an amount that cannot be leaked [Borgstr.
, and K., 0hlssonxScand, J.
, Cl1n, Lab, Invest, 36 8
09-814 (19〕6)〕,〕α, -AT-T The development of the O leakage method is l! It is thought that this will provide a useful tool for disease diagnosis.

一方、血清中トリプシンをその存在様式別に定量する賦
みはなされているが、それらの方法[Brodrlmk
、 J、 W、 、  M、 C,G@okas、 C
,Largmn。
On the other hand, although methods have been developed to quantify trypsin in serum according to its mode of existence, these methods [Brodrlmk
, J, W, , M, C, G@okas, C
, Largmn.

M、Fams*tt、and  J、H,Johnso
n %  Am、J、Physial。
M, Fams*tt, and J, H, Johnson
n% Am, J, Physial.

237、 E474−E480 (1979) &びB
@rgstrWm、 A。
237, E474-E480 (1979) &B
@rgstrWm, A.

s+ad K、 0hlss*n s H@pps−8
@yl@r’s Z、 Phymlol。
s+ad K, 0hlss*n s H@pps-8
@yl@r's Z, Phymlol.

Ch@m、 359677−681 (1978)) 
は面清をゲル鍵−法により分+m後トリプシンの放射性
免疫測定法を用いるものであり、li!床診断法への適
用は国電である。
Ch@m, 359677-681 (1978))
This method uses trypsin radioimmunoassay after 1000 min by gel key method, and li! The application to the floor diagnosis method is Kokuden.

壕だ、従来から、体液中の微量成分を測定する手段とし
て、抗原の検索を免疫学的Kll定する方法(ゲル内免
疫拡散法、補体結合法、IIjA麿球凝集反応叫)か広
く使用されているが、測定感度の向上の面から放射性免
疫測定法(ラジオイムノアッセイ)が用いられるように
なって亀た。しかしながら、放射性免疫濶定法社放射性
物質による環境汚染1人体への影響という面で間鵬かあ
る。
Traditionally, immunological determination methods (in-gel immunodiffusion method, complement fixation method, IIJA murine agglutination reaction) have been widely used as a means of measuring trace components in body fluids. However, radioimmunoassay (radioimmunoassay) came into use due to its improved measurement sensitivity. However, there is still some controversy regarding the effects of environmental pollution caused by radioactive substances on the human body under the Radioactive Immunization Act.

本発劉試sit用いるサンドウィッチ法による酵素免疫
滴定法は抗原−抗体結合を利用して、酵素で確論した抗
IfjLもしくね抗体を使用し、抗原−抗体結合物を生
成せしめ、得られた物質の酵素活性を測定することによ
り、未知抗原量もしく#−i抗体量を判定しようとする
ものであって、サンドウィッチ法もその一つである。こ
のナンドウィッチ法は愉赦の抗原基を有する抗原K。
The enzyme immunotitration method using the sandwich method using the present Liu test site utilizes antigen-antibody binding and uses anti-IfjL or Shikune antibodies established with enzymes to generate antigen-antibody conjugates. The sandwich method is one of the techniques used to determine the amount of unknown antigen or #-i antibody by measuring the enzyme activity of a substance. This Nandwich method uses antigen K, which has a specific antigenic group.

働数の抗体が結合する仁とを利用し、抗体−抗wLIs
Iil!抗体のサンドウィッチ麺結合物を生!させ、そ
ous+抗体の酵素活性を測定することにより、抗原量
を1NIIhLようとする方法であって、他の免疫学的
測定法に比較し、50〜10,000倍感度が高いとい
う利点がある。そこで、本発明者らは各m疾患における
α、−^’re丁の変動を検索すべく、ヒト体液中のα
、−AT@Tの酵素免疫測定法に関し、鋭意に研究を重
ね、本発明物質を得ることに成功した。
Antibody-anti-wLIs
Iil! Raw antibody sandwich noodle conjugate! This method attempts to estimate the amount of antigen by 1 NII hL by measuring the enzyme activity of the sous+ antibody, and has the advantage of being 50 to 10,000 times more sensitive than other immunoassay methods. . Therefore, the present inventors aimed to search for changes in α, -^'re in each m disease.
, -We have conducted extensive research on the enzyme immunoassay method for AT@T, and have succeeded in obtaining the substance of the present invention.

すなわち、本発#IFi、精ししたヒト血清中アルファ
ー−1−アンチトリプシンを抗原として得られる抗アル
ファーー1−アンチトリズシン抗体をe票と共有結合に
より結合した酵素swk抗体と、精製したヒト膵臓トリ
プシンを抗原として得られる一抗トリズシン抗体を共有
結合tたは物理的吸着により不溶性相体に結合した不溶
化抗体とからなるサンドウィッチ法によるヒト体llの
アルファー−1−アンチトリプシン・トリプシン結合#
泗定用試桑に関する。
Specifically, #IFi of the present invention, an enzyme swk antibody obtained by covalently bonding an anti-alpha-1-antitrypsin antibody obtained using purified human serum alpha-1-antitrypsin as an antigen, and a purified human pancreatic pancreas. Binding of alpha-1-antitrypsin to trypsin in a human body by a sandwich method consisting of an anti-trypsin antibody obtained using trypsin as an antigen and an insolubilized antibody bound to an insoluble phase by covalent binding or physical adsorption.
Concerning test mulberry for determination.

本発明の賦亀は、次のように製造することができる。す
なわち、ヒトのα、−AT及びトリプシンを各大家兎に
感作して抗α1−A丁抗体及び抗トリプシン抗体を作製
し、つきに抗トリプシン抗体をポリスプレンビーズ、ガ
ラスピーズ、ナイロンビーズ輯の不溶性相体と処理し、
抗トリプシン抗体の結合した不溶化抗体を得る。一方で
、抗α、−AT抗体に1使用する酵素に最適1kijI
僑剤(@えはβ−ガラクトシダー(に対し襲−マレイン
イミドベンゾイル−N−ヒドロキクナクシンイミドエス
テル、パーオキシダーゼに対しグルメルアルテヒド及び
過画つ素ll!尋)により酵素を順次反応させて綽素橡
議抗α、−ムi抗体を得る。この場合、架橋剤と酵素を
先に反応させて後、抗体を結合させてもよい。
The turtle of the present invention can be manufactured as follows. That is, anti-α1-A antibody and anti-trypsin antibody were produced by sensitizing each rabbit with human α, -AT and trypsin, and then the anti-trypsin antibody was sensitized to polysprene beads, glass beads, and nylon beads. treated with an insoluble phase;
An insolubilized antibody bound to an anti-trypsin antibody is obtained. On the other hand, the most suitable enzyme for anti-α, -AT antibody is 1kijI.
The enzymes are sequentially reacted with external agents (β-galactosidase (maleimidobenzoyl-N-hydrochunacinimide ester), peroxidase (gumeraltehyde), and hyperpigmentation (hyperoxidase)). A crosslinking agent and an enzyme may be reacted first, and then the antibody may be bound to the antibody.

このようにして得られ九抗トリズシン抗体結合相体と酵
素−−抗α1−ムT抗体を用い、ヒト体液中のα、−^
TΦ丁の測定が可能となっ九。
Using the nine anti-trizucin antibody-bound phase obtained in this way and the enzyme-anti-α1-muT antibody, α, -^ in human body fluids was used.
It became possible to measure TΦ.

し良がって、本発倒物質社膵疾患O診断に有用である。Therefore, the present drug is useful for diagnosing pancreatic diseases.

次に実施例を挙げて更に詳細に説−する。Next, a more detailed explanation will be given with reference to examples.

実  施  例 (1)α鳳−ムT抗体の作龜 販兎1匹に対して精製α、−AT0.7511fを含む
浴液1mgをFr@unシのコンプリート・アジュバン
ト (C叫1・t・adjuマant)1−混合して作
製した乳剤を背中の皮下及び四肢の爪の間に注射する。
Example (1) Preparation of α-T antibody 1 mg of a bath solution containing purified α,-AT0.7511f was added to one rabbit using Fr@unshi's complete adjuvant (C-1・T・Adju mother ant) 1 - Inject the mixed emulsion prepared subcutaneously on the back and between the nails of the extremities.

絽1−目の免疫から2m間後に第1同目と同様の乳剤を
家兎の皮下に注射し皮。同様な免疫操作を2〜31gI
繰り返し死後、家兎の朧動脈より血液を採取し、37°
C130分間の加温後、3.000 rym、 15分
遠心を行い血清を得る。この血清につき56°C130
分の熱処理を行い、補体の非動化を行い、0.9%塩化
ナトリウム溶液を血清と同量加え、更に血清と同容量の
飽和il@アンモニウムを加えて33%飽和とし、そこ
で析出する沈澱を12.00Orpm、15分の遠心に
より集め、少量の20Fl1MリンIIIIII衡液(
pH8,0)に溶解後、同緩衝液を用いて透析を行い、
値鹸アン毫ニウムを完全に除く。ここで得られた一分を
20mMリン酸緩徴液(pH8,0)によ11化され九
DEAI−セルロースカラム(2,5X20eIIM)
に添加し、カラムに吸着せず同上緩衝液により流出する
一分を集め20sf/−のタンパク量になるように同上
緩衝液により、希釈し、これを抗α、−ムT抗体とし、
それぞれを分注し、凍結乾燥し一30°Cで保存する。
1 - 2 m after the immunization of the first rabbit, the same emulsion as the first one was injected subcutaneously into the rabbit's skin. Similar immunological manipulations were performed for 2 to 31 g I
After repeated death, blood was collected from the rabbit's hazy artery, and the blood was collected at 37°
After heating for 130 minutes, centrifuge at 3,000 rym for 15 minutes to obtain serum. 56°C130 for this serum
Heat treatment for 30 minutes to immobilize complement, add 0.9% sodium chloride solution in the same amount as the serum, and then add the same volume of saturated IL@ammonium as the serum to make it 33% saturated, where it is precipitated. The precipitate was collected by centrifugation at 12.00 rpm for 15 minutes, and a small amount of 20Fl1M phosphorus III solution (
After dissolving in pH 8,0), dialysis was performed using the same buffer,
Completely eliminates the value of annium. One minute obtained here was converted to 11 with 20mM phosphate buffer solution (pH 8.0) and placed on a nine DEAI-cellulose column (2.5X20eIIM).
Collect the fraction that does not adsorb to the column and flow out with the same buffer, dilute it with the same buffer to a protein amount of 20sf/-, and use this as anti-α, -muT antibody.
Aliquot each, lyophilize and store at -30°C.

(2(抗トリプシン抗体の作製 家兎l四に対してヒト膵液より精製し九トリグシン0.
611fを含む溶液l−を使用する以外は前記(1)と
同様に操作を行い、抗トリプシン抗体をII九。
(2) Preparation of anti-trypsin antibodies Purified from human pancreatic juice against 14 rabbits and 9 trypsin 0.
The same procedure as in (1) above was carried out except that solution 1- containing 611f was used, and the anti-trypsin antibody was added to 1-9.

(3) 抗トリノシン抗体結合ポリスチレンビーズ01
1111k凍結乾燥し九抗体200岬を5011M壊化
ナトリクムを含む0.1Mリン酸ナトリウムa論蒙(p
H7,6)400ml@解し、この溶液中に、十分洗浄
(強力な洗剤勢による)し九ポリスチレンビーズ(直径
約6.5g)を1,000〜2,500個加え30°C
で2時間振とうする。抗体港鎗を除いた後、0゜1襲ウ
シ鹿清アルプンンを含む同上III衝液でビーズを洗浄
後、−緩衝液を加え、さらに30°Cで2時r11*と
うする。さらに同11&液で洗浄後、アジ化ナトリウム
濃度が001%になるように加え、同一緩衝液中にビー
ズを保存する。
(3) Anti-trinosine antibody-conjugated polystyrene beads 01
1111k lyophilized nine antibodies 200 cape was added to 0.1M sodium phosphate aronmeng containing 5011M disintegrated sodium (p
Dissolve 400ml of H7,6), add 1,000 to 2,500 polystyrene beads (approximately 6.5g in diameter) that have been thoroughly washed (with a strong detergent) into this solution, and heat at 30°C.
Shake for 2 hours. After removing the antibody droplets, the beads were washed with the same buffer solution III as above containing 0.1 ml of 0.1-glycide, then a -buffer was added, and the beads were incubated at 30°C for 2 hours. After washing with the same buffer solution No. 11, sodium azide is added to the solution so that the concentration becomes 0.01%, and the beads are stored in the same buffer solution.

(4)Kljフシン抗$IML合ガラスピーズのThe
ガラスピーズ(直径約4■) 5,000〜10.00
0個を10%r−アミノプロピル・トリエトキシシラン
を含むトルエン溶液200 sdに加え30分間室温で
反応後、上記溶液をガラスフィルターにて除去し、トル
エンにて十分洗浄後、アルキルアミン化ガラスピーズを
t燥し死後、0.2%抗トリ1シン抗体を含有すル20
mM !j y*緩衝11k (pH7,4) 500
−千に加え、よく攪拌しなからグルタルアルデヒドを終
漉度0.1−1%になるように加え、40c にて12
時間振とう反応させる。ここで得られた抗トリプシン抗
体結合ガラスピーズを0.1%ウシ血清アルブミンを含
有する0、IMリン酸ナトリウA11lli’l (p
H7,0) K テ十分に洗浄後、0.1%アジ化ナト
リウムを含む同上IIIIII液50〇−中に4°Cに
て保存する。
(4) The Klj Fusin anti-$IML laminated glass beads
Glass peas (approx. 4cm in diameter) 5,000~10.00
0 pieces were added to 200 sd of toluene solution containing 10% r-aminopropyl triethoxysilane, and after reacting at room temperature for 30 minutes, the solution was removed with a glass filter, and after thorough washing with toluene, alkyl aminated glass beads were added. After drying and post-mortem, 20 μl containing 0.2% anti-tricine antibody was added.
mm! j y*buffer 11k (pH7,4) 500
-1,000, stir well, add glutaraldehyde to a final straining degree of 0.1-1%, and boil at 40℃ for 12 hours.
Shake for a time to react. The anti-trypsin antibody-bound glass beads obtained here were mixed with 0, IM sodium phosphate A11lli'l (p) containing 0.1% bovine serum albumin.
H7,0) After thorough washing, store at 4°C in the same solution III containing 0.1% sodium azide.

(51抗トリプシン抗体結合ナイロンビーズのl1ll
製ナイロンビーズ(直径約3−) 1,000〜10.
000個t12.5%トリエチル・オキソニウム・テト
ラフルオロボレートを含むジクロルメタン溶fi100
mK加え25°Cで15分間反応後、水素化カルシウム
で水分を除いえジクロルメタン500 wIItKて洗
浄する。上記O−アルキル化ナイロンビーズをシアにツ
メタン10〇−中に加えて、型温で2時間反応後、0.
2Mホウ酸緩衝液(pH8,5) 500mKて洗浄後
、5≦グルタルアルデヒドを含む同上緩衝液100−中
に加えて室温で15分反応させる。このビーズをさらK
 20jmMリン酸カリウム緩衝液(pH7,0) 5
00wdで洗浄後、1 %’m O抗体を含む四上緩―
液50〇−中に加え、4°Cで一夜反応を行い、0.1
%ウシ自清アルプンン、0.l憾アジ化ナトリウムを含
む20111Mリン酸カリウム緩働*(pH7,0)で
十分洗浄し死後、同上緩衝液中で4°CKて保存すゐ。
(11ll of 51 anti-trypsin antibody-conjugated nylon beads)
Made of nylon beads (approx. 3-diameter) 1,000 to 10.
000 pieces T12.5% dichloromethane solution containing triethyl oxonium tetrafluoroborate fi100
After adding mK and reacting at 25°C for 15 minutes, water was removed with calcium hydride and washed with dichloromethane 500 wIItK. The above O-alkylated nylon beads were added to shea in Tsumethane 100, and after reacting at mold temperature for 2 hours, 0.
After washing with 500 mK of 2M boric acid buffer (pH 8.5), it is added to the same buffer solution 100 containing 5≦glutaraldehyde and allowed to react at room temperature for 15 minutes. K out these beads.
20jmM potassium phosphate buffer (pH 7,0) 5
After washing with 00wd, a four-layer solution containing 1%'mO antibody was added.
Add to solution 500- and react at 4°C overnight.
% Bovine Self-cleaning Alpunun, 0. After washing thoroughly with 20111M potassium phosphate slow release* (pH 7.0) containing sodium azide, and after death, store in the same buffer solution at 4°C.

(6) パーidシ1−41!ish抗at−h’r抗
体of111m西洋ワサビから精製され九パーオキシタ
ーセ(POD)20qを1.25%グルタルアルデヒド
を含む0.1Mリン酸緩衝液(pH6,8)0.3mに
溶解し、室温で18時間反応ずゐ。グルタルアルテヒド
化PODをo、 154M jJi化ナトナトリウ緩機
化され友セファテックスG−25カラム(1゜5X60
a+)K添加し、遊離のグルタルアルテヒドを除く。上
記クルクルアルデヒド化POD溶液に抗体lO岬を溶解
、さらK 114炭醗緩alIf&(pH9,5) 0
.2 mを加え、4°Cで24時間反応後、0゜2M 
L−リジンを加え、室温で2時間反応させる。上記反応
液をO,154M橋化ナトリウムを含むIOIILMリ
ンmmm液(pH7゜2)により緩機化させ九セファデ
ックスG−200カラム(1,5X 70m) K g
li加し、POD Q麺抗体を得る。POD活性を有す
る抗体−分を集め終濃度0.01%になるようにチオメ
ルサールを加え、ざらK 1iIfJ量のグリセリンを
加え、4°CK保存する。
(6) Per ID 1-41! ish anti-at-h'r antibody of111m Nine peroxitase (POD) purified from horseradish (POD) 20q was dissolved in 0.3 m of 0.1 M phosphate buffer (pH 6,8) containing 1.25% glutaraldehyde and incubated at room temperature. No reaction for 18 hours. Glutaraltehyde POD was added to 154M jJI sodium chloride softened Sephatex G-25 column (1゜5X60
a+) Add K and remove free glutaraltehyde. Dissolve the antibody lO cape in the above curcuraldehyde POD solution, and then add K114 charcoal chloride alIf & (pH 9,5) 0
.. 2M was added, and after reacting at 4°C for 24 hours, 0°2M
Add L-lysine and react at room temperature for 2 hours. The above reaction solution was loosened with IOIILM phosphorus solution (pH 7°2) containing O, 154M sodium bridging, and loaded onto a Sephadex G-200 column (1.5X 70m) K g
li to obtain POD Q noodle antibody. Collect the antibodies having POD activity, add thiomersal to a final concentration of 0.01%, add a large amount of glycerin, and store at 4°C.

(7)β−カシクトシターゼ41融抗α、−^T抗体の
−製凍結乾燥し九抗体1.5qを50111M塩化ナト
リウムを含む0.1Mリン酸ナトリウム緩* *−7,
5)1.5mK1@解し、これに2襲講−マレインイミ
ドベンゾイル−N−ヒドロキシ・ナタクンイミド・エス
テル<MIIB)のジオ中すン溶筐15、lを加え、3
0°Cで1時間反応費、同上50mM塩化マグネシウム
、0.1M塩化ナトリウムを含む5073!Mリン鰻ナ
トリウム緩衝波−H7、ち)KよりIIIJ化され九カ
ラム客験#3o−のセファデックスG−25カラムクロ
マトグツフイーにで、遊離のMBSを除きMBS化抗体
を得る。このMBS化抗体溶液K E、 C・11産生
I−ガラクトシダーゼ1.5岬を加えて、30°Cで1
##間反応後、最終濃度1mMKなゐようにメルカプト
エタノールを加え石。さらに/−ガラクトシターゼ標論
抗体を0.1%ウシ自清アルブミン、0.1%アジ化ナ
トリウム、0.1M塩化ナトリウム、1111M壌化マ
グネタウムを含むlOrlLMリン酸ナトリウム緩衝液
(pH7,0)テm価化されたセファロース48 力j
ム(1,5x 40cm ) K fA加し、β−ガラ
クトシダーゼ結合抗体を分離する。β−ガラクトシダー
ゼ活性を有する抗体−分のピークを集め、β−ガラクト
シダーゼ標1抗体とし4°Cて保存する。
(7) β-Casictosidase 41 fused anti-α,-^T antibody - lyophilized 1.5q of nine antibodies in 50111M sodium chloride-containing 0.1M sodium phosphate* *-7,
5) Dissolve 1.5 mK1@, add 15 liters of 2-maleimidobenzoyl-N-hydroxy natakunimide ester (MIIB) to it, and
5073 containing 50mM magnesium chloride, 0.1M sodium chloride, 1 hour reaction time at 0°C! Free MBS was removed using a Sephadex G-25 column chromatograph using M phosphorus sodium buffer (H7), K to IIIJ, and a nine-column test #3o to obtain an MBS-formed antibody. Add 1.5 caps of this MBS-conjugated antibody solution KE, C-11-producing I-galactosidase, and incubate at 30°C for 1 hour.
After the reaction, add mercaptoethanol to a final concentration of 1mM. Additionally/- galactosidase labeled antibody was added to lOrlLM sodium phosphate buffer (pH 7.0) containing 0.1% bovine autologous albumin, 0.1% sodium azide, 0.1M sodium chloride, and 1111M magnetium chloride. Tempered Sepharose 48 force j
(1.5 x 40 cm) KfA is added to separate the β-galactosidase-bound antibodies. The peak of the antibody having β-galactosidase activity is collected and stored at 4°C as β-galactosidase labeled 1 antibody.

実験例1 (11抗トリプシン抗体結合ポリスチレンビーズを用い
る方法(方法1) 精製したα、−ムTと精製トリプシンを中性pHにて1
対10モル比で混合してIIl&した濃度既知の標準α
、 −kTaT溶* (0,2,0,4,0゜8.0 
、 16.0.32.0.64゜0. 128,256
呼150μL)あるいFi測定対象試料を50声tすっ
とり、次KO11%ウシ血清アルブミン、0゜01%デ
オメルサール、IOIIIM塩化ナトリウムを含むlO
罵Mリン酸!I!衡液(pa7.0)(バッファーP)
を200μ加えて、前記(3)で得られ良抗体結合ポリ
スチレービーズを七れぞれ1個加え、37°Cで2時間
反応後、2.0−のバッファーPKで2回洗浄する。こ
のビーズに*IIk’、 (6+のPOD欅麺抗体溶液
をバッファーPKて100倍希釈し九洛液を0.3−加
え、37°Cで3時間反応し、2−のバッファーPにて
2−洗浄を行う。洗浄されたビーズを別の試験管に取り
、0.3襲オルトフエニレンジアミンニ塩@*、 0.
025G過酸化水素及び0.01%テオメルデールを含
む0.1Mクエン酸−リン酸緩衝液(pH6,0)0.
2−を加えて37°Cで15〜20分間反応を行い、I
N撫112.0−を加えた後、492算罵で吸光度測定
を行う。第1図aは拳法によゐα、−Aτ−τの標準画
−を示す。
Experimental Example 1 (Method using 11 anti-trypsin antibody-conjugated polystyrene beads (Method 1) Purified α,-muT and purified trypsin were mixed at neutral pH.
and a standard α of known concentration by mixing at a molar ratio of 10
, -kTaT solution* (0,2,0,4,0°8.0
, 16.0.32.0.64゜0. 128,256
150 μL) or the sample to be measured for Fi, diluted with 50 liters of water, then diluted with lO containing 11% bovine serum albumin, 0.01% deomersal, and IOIIIM sodium chloride.
Abusive M phosphoric acid! I! Equilibrium (pa7.0) (buffer P)
Add 200μ of each of the seven well-bound polystyrene beads obtained in (3) above, react for 2 hours at 37°C, and wash twice with 2.0-buffer PK. To these beads, *IIk', - Perform washing. Take the washed beads into another test tube and add 0.3 orthophenylenediamine di-salt @*, 0.
0.1M citric acid-phosphate buffer (pH 6.0) containing 025G hydrogen peroxide and 0.01% Theomerdale.
2- was added and reacted at 37 °C for 15-20 minutes,
After adding 112.0-N, absorbance is measured at 492-N. Figure 1a shows the standard drawing of α, -Aτ-τ according to Kenpo.

(2)抗トリプシン抗体結合ポリスチレンビーズを用い
る方法(方法2) 測定対象試料50ILtあるいは濃度既知榔準α1−ム
T・丁 溶液 (0、2,0,4,0,8,0,16,
0゜32.0.64.0. 128.256呼150μ
j)504を取り、最終容量250MKなるようKO,
1−ウシ血清アルブミン、0.1%アジ化ナトリウム、
11mM塩化マグネシウム、  10+sM植化ナトリ
ウムを含むIOIIMリン酸緩倫液(pH7,0)(バ
ッファーE)を加えて、!11紀(3)で得うれた抗体
結合ポリスチレンビーズをそれぞれ1個加え、37°C
で2時間反応後、2.0−のバッファーEKて2廂洗浄
する。このビーズに250μtのバッファーE及び約紀
(71のβ−ガラクトシダーゼ411I−抗体溶$5μ
tを加え、370Cて3時間反応させ、2゜0−のバッ
ファーEにテ21&i1洗浄を行う。洗浄されたビーズ
をN0Ektに取り、200gのバッファーgt加え、
30°Cで5分間予備加温の後、0.371M4−メチ
ルウンベリフェリル−β−ガラクトシ、ド溶液100I
Ltを加えて30°Cで5〜20分間反応1行い、0.
1Mグリシン−水酸化ナトリウム緩衝11 (PH10
,3)を2.5111/加え良後、励起波長360ル講
、螢光波長450ルrat/Cて螢光漏電し、ρ−ガラ
クトシターゼの酵素活性を〜定する。亀2図1は拳法に
よるα、−AT”Tの標準曲線をボす〇 実験例2 ゐ方法(方法l) 前記(4)で1#龜した抗トリプシン抗体結合ガラスと
−ズを使用する以外は実験例1の(1)と同様に操作を
行う。ただし、拳法によるα1AT−Tの標準曲線を第
t*btc示した。
(2) Method using anti-trypsin antibody-conjugated polystyrene beads (Method 2) Measurement sample 50ILt or a standard α1-T solution with known concentration (0, 2, 0, 4, 0, 8, 0, 16,
0°32.0.64.0. 128.256 calls 150μ
j) Take 504 and KO it so that the final capacity is 250MK,
1-Bovine serum albumin, 0.1% sodium azide,
Add IOIIM phosphate buffer solution (pH 7.0) (buffer E) containing 11mM magnesium chloride and 10+sM inoculating sodium. Add one antibody-conjugated polystyrene bead obtained in 11th century (3) to each, and heat at 37°C.
After reacting for 2 hours, wash twice with 2.0-buffer EK. Add 250 µt of Buffer E and approximately 71 β-galactosidase 411 I-antibody solution to the beads at $5 µl.
Add t, react at 370C for 3 hours, and wash with 2°0- buffer E. Take the washed beads in N0Ekt, add 200g of buffer gt,
After prewarming at 30°C for 5 minutes, add 100 I of a 0.371 M 4-methylumbelliferyl-β-galactosyde solution.
After adding Lt, one reaction was carried out at 30°C for 5 to 20 minutes.
1M glycine-sodium hydroxide buffer 11 (PH10
, 3) was added at 2.5111/C, and then the excitation wavelength was 360 l/C and the fluorescence wavelength was 450 l/C to cause a fluorescence leakage to determine the enzymatic activity of ρ-galactosidase. Figure 2 shows the standard curve of α, -AT''T by Kempo Experimental Example 2 Method (Method 1) Other than using the anti-trypsin antibody-conjugated glass and -s pre-diluted in (4) above. The operation was performed in the same manner as (1) of Experimental Example 1. However, the standard curve of α1AT-T by Kenpo is shown at t*btc.

(2)  抗トリプシン抗体結合ガラスピーズを用いる
方法(方法2) 前記(4)でw!!ibし走航トリプシン抗体結合ガラ
スピーズを使用する以外は実験例1の(2)と同様に操
作を行う。ただし、拳法によゐα、−AT@Tの標準面
−を謝2図すに示し良。
(2) Method using anti-trypsin antibody-conjugated glass beads (Method 2) In (4) above, lol! ! The procedure is carried out in the same manner as in (2) of Experimental Example 1, except that trypsin antibody-conjugated glass beads are used. However, according to Kempo, the standard side of AT@T can be shown in Figure 2.

実験例3 (])  抗トリプシン抗体結合ナイロンビーズを用い
る方法(方法l) 前記(5)で−製し走航トリプシン抗体結合ナイロンビ
ーズを使用すゐ以外は実験例1の(1)と同様に操作を
行う0ただし、拳法によるα1−AT@Tの標準曲線を
第1図@に示した。
Experimental Example 3 () Method using anti-trypsin antibody-conjugated nylon beads (Method 1) Same as (1) of Experimental Example 1 except that the nylon beads conjugated to trypsin antibody prepared in (5) above were used. However, the standard curve of α1-AT@T by Kempo is shown in FIG.

(2)  抗トリプシン抗体結合ナイロンビーズを用い
る方法(方法2) 1紀(5)で−製し九抗トリプシン抗体結合ナイロンと
−ズを使用する以外は実験例1の(2)と1IfJ橡の
操作を行う。たたし、拳法によるα8−AT・丁の砿阜
#劇を絡2図Cに示した。
(2) Method using anti-trypsin antibody-conjugated nylon beads (Method 2) Experimental example 1 (2) and 1IfJ beads were used except that 9 anti-trypsin antibody-conjugated nylon beads prepared in step 1 (5) were used. Perform operations. However, the Kōfu #play of α8-AT and Ding by Kenpo is shown in Figure 2C.

各実験例における標準α、−AT・T、血清における同
時再現性及び日差変動を第1表及び第2表にボす。
Tables 1 and 2 show the simultaneous reproducibility and day-to-day fluctuations in standard α, -AT·T, and serum in each experimental example.

第1表  POD 11m1k抗体を用いたα、−AT
・Tの鉾素免疫淘定法のP)視性 第2表  β−ガラクトシダーゼll1l&抗体を用い
九α、−A丁φ丁の絆嵩免疫潟定 法の再現性 β−Gaj:/−ガフクトシターゼam抗体POD :
  POD棒論抗論 抗体各検体の同時再現は51mの濃度の興なる検体の1
0回繰り返し実験を行つ友結果である。
Table 1 α,-AT using POD 11m1k antibody
・P) Visibility Table 2 of T's immunoselection method Reproducibility of Kizada immunoselection method of β-galactosidase ll1l & antibody POD :
Simultaneous reproduction of each sample with POD theory and anti-antibody is one of the most important samples with a concentration of 51m.
This is the result of repeating the experiment 0 times.

Z各検体の日M変動は511の濃度Opiなる検体をl
O日日間り返し実験を行つえ結果である。
Z The daily M variation of each sample is 511 concentration Opi sample.
These are the results of repeated experiments for O days.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図及び第2図は本発明の実験例l〜3におけるα、
−ムT−Tt)II皐曲口を示すグラフで、既知渉度−
準α、−AT−T量を横軸に対数で取り、PODを標準
酵素として用いた場合は吸光度を、β−ガラクトシダー
ゼを標準酵素として用いた場合口鉾素活性を縦軸に取っ
たものである。 特許出願人   マルコ製薬株式会社
FIGS. 1 and 2 show α in experimental examples 1 to 3 of the present invention,
-MuT-Tt) II A graph showing the entrance of the bend, with a known degree of crossing-
The amount of quasi-α,-AT-T is plotted on the horizontal axis as a logarithm, and the absorbance is plotted on the vertical axis when POD is used as the standard enzyme, and the cholinergic activity is plotted on the vertical axis when β-galactosidase is used as the standard enzyme. be. Patent applicant: Marco Pharmaceutical Co., Ltd.

Claims (1)

【特許請求の範囲】[Claims] 1゜精製し九ヒト自清中アルファーー1−アンチトリグ
シンを抗原として得られる抗アルファーー1−アンチト
リプシン抗体を酵素と共有結合により結合し九紳素榔論
抗体と、精製し九ヒト膵臓トリプシンを抗原として得ら
れる抗トリズシン抗体を共有結合普たは物珈的吸着によ
り不溶性担体に結合した不溶化抗体とからなるサンドウ
ィッチ法によるヒト体液中のアルファー−1−アンチト
リプシン・トリズシン結合物測定用試薬。
1. The anti-alpha-1-antitrypsin antibody obtained by using purified nine-human alpha-1-antitrypsin in autonatant serum as an antigen was covalently linked to an enzyme and purified nine-human pancreatic trypsin antibody. A reagent for measuring alpha-1-antitrypsin/trizucin conjugates in human body fluids by a sandwich method comprising an anti-trizucin antibody obtained as an antigen and an insolubilized antibody bound to an insoluble carrier by covalent bonding or physical adsorption.
JP3171382A 1982-03-02 1982-03-02 Reagent for measuring bound material of alpha-1- antitrypsin-trypsin in human body fluid by sandwich method Pending JPS58148963A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3171382A JPS58148963A (en) 1982-03-02 1982-03-02 Reagent for measuring bound material of alpha-1- antitrypsin-trypsin in human body fluid by sandwich method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3171382A JPS58148963A (en) 1982-03-02 1982-03-02 Reagent for measuring bound material of alpha-1- antitrypsin-trypsin in human body fluid by sandwich method

Publications (1)

Publication Number Publication Date
JPS58148963A true JPS58148963A (en) 1983-09-05

Family

ID=12338702

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3171382A Pending JPS58148963A (en) 1982-03-02 1982-03-02 Reagent for measuring bound material of alpha-1- antitrypsin-trypsin in human body fluid by sandwich method

Country Status (1)

Country Link
JP (1) JPS58148963A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159025A2 (en) * 1984-04-17 1985-10-23 Teijin Limited Monoclonal antibody specific to human alpha2-plasmin
JPS6134465A (en) * 1984-07-26 1986-02-18 Teijin Ltd Immunoassay reagent and kit using monoclonal antibody against human alpha2-plasmin inhibitor
WO1991005257A1 (en) * 1989-10-02 1991-04-18 Teijin Limited Kit for immunoassay of human tissue plasminogen activator/human plasminogen activator inhibitor complex and method of immunoassay
JP2023125474A (en) * 2022-02-28 2023-09-07 住友ベークライト株式会社 Reagent for serine protease detection or measurement

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159025A2 (en) * 1984-04-17 1985-10-23 Teijin Limited Monoclonal antibody specific to human alpha2-plasmin
JPS6134465A (en) * 1984-07-26 1986-02-18 Teijin Ltd Immunoassay reagent and kit using monoclonal antibody against human alpha2-plasmin inhibitor
JPH0441783B2 (en) * 1984-07-26 1992-07-09 Teijin Ltd
WO1991005257A1 (en) * 1989-10-02 1991-04-18 Teijin Limited Kit for immunoassay of human tissue plasminogen activator/human plasminogen activator inhibitor complex and method of immunoassay
JP2023125474A (en) * 2022-02-28 2023-09-07 住友ベークライト株式会社 Reagent for serine protease detection or measurement

Similar Documents

Publication Publication Date Title
USRE31006E (en) Process for the demonstration and determination of reaction components having specific binding affinity for each other
CA1160566A (en) Immunological determination method
USRE29169E (en) Process for the demonstration and determination of reaction components having specific binding affinity for each other
CA1040082B (en) Process for the demonstration and determination of reaction components having specific binding affinity for each other
Tejwani et al. The purification of properties of rat liver fructose 1, 6-bisphosphatase
JPH0445520B2 (en)
KR880001338B1 (en) Method and reagent for use in the assay of pivka-ii
JPS58148963A (en) Reagent for measuring bound material of alpha-1- antitrypsin-trypsin in human body fluid by sandwich method
JPS6222065A (en) Manufacture of zygote from marked enzyme proper to measurement of enzyme immunity and immunization substance
US4966838A (en) Process for the immunological quantitative determination of T3 and/or T4 thyroid hormones, using thyroglobulin
Zager et al. Radioimmunoassay for urinary renal tubular antigen: A potential marker of tubular injury
JPS5990054A (en) Method and reagent for immunochemical mesurement of human chorionic gonadotropin
JPS62106369A (en) Immunoassay
JPS604423B2 (en) Method for quantifying peptide hormones
JP2543630B2 (en) Measuring method of glycation ratio of specific protein
Matzku et al. Radioimmunological quantitation of human group-II pepsinogens
CA1193192A (en) Method of determinination of human urine kallikrein and kit for the same
CA1195612A (en) Reagent for determination of human urine kallikrein
Arima et al. Serum glycoproteins in the liver diseases: I. Studies on sialic acid-free glycoproteins-improved competitive binding assay of desialylated glycoprotein by rat liver plasma membrane
JPH07313186A (en) Anti-pivka-ii monoclonal antibody
JPS587560A (en) Reagent for measuring copper, zinc-super oxidedismutase
JPS6140066B2 (en)
CA1100869A (en) Use of tri-iodo thyronine bonded to an enzyme in the determination of the concentration of tri-iodo thyronine
RU2195664C2 (en) Method of determining functional activity of c3 component of human complement
JPS60169766A (en) Reagent for fractional measurement of soluble fraction aspartic acid aminotransferase and mitochondria aspartic acid aminotransferase